Synchronous resection of esophageal cancer and other organ malignancies: A systematic review

World J Gastroenterol. 2019 Jul 14;25(26):3438-3449. doi: 10.3748/wjg.v25.i26.3438.

Abstract

Background: Neoplasms arising in the esophagus may coexist with other solid organ or gastrointestinal tract neoplasms in 6% to 15% of patients. Resection of both tumors synchronously or in a staged procedure provides the best chances for long-term survival. Synchronous resection of both esophageal and second primary malignancy may be feasible in a subset of patients; however, literature on this topic remains rather scarce.

Aim: To analyze the operative techniques employed in esophageal resections combined with gastric, pancreatic, lung, colorectal, kidney and liver resections and define postoperative outcomes in each case.

Methods: We conducted a systematic review according to PRISMA guidelines. We searched the Medline database for cases of patients with esophageal tumors coexisting with a second primary tumor located in another organ that underwent synchronous resection of both neoplasms. All English language articles deemed eligible for inclusion were accessed in full text. Exclusion criteria included: (1) Hematological malignancies; (2) Head/neck/pharyngeal neoplasms; (3) Second primary neoplasms in the esophagus or the gastroesophageal junction; (4) Second primary neoplasms not surgically excised; and (5) Preclinical studies. Data regarding the operative strategy employed, perioperative outcomes and long-term outcomes were extracted and analyzed using descriptive statistics.

Results: The systematic literature search yielded 23 eligible studies incorporating a total of 117 patients. Of these patients, 71% had a second primary neoplasm in the stomach. Those who underwent total gastrectomy had a reconstruction using either a colonic (n = 23) or a jejunal (n = 3) conduit while for those who underwent gastric preserving resections (i.e., non-anatomic/wedge/distal gastrectomies) a conventional gastric pull-up was employed. Likewise, in cases of patients who underwent esophagectomy combined with pancreaticoduodenectomy (15% of the cohort), the decision to preserve part of the stomach or not dictated the reconstruction method (whether by a gastric pull-up or a colonic/jejunal limb). For the remaining patients with coexisting lung/colorectal/kidney/liver neoplasms (14% of the entire patient population) the types of resections and operative techniques employed were identical to those used when treating each malignancy separately.

Conclusion: Despite the poor quality of available evidence and the great interstudy heterogeneity, combined procedures may be feasible with acceptable safety and satisfactory oncologic outcomes on individual basis.

Keywords: Concurrent neoplasms; Esophageal neoplasm; Esophagectomy; Management; Multiple primary; Second primary.

Publication types

  • Systematic Review

MeSH terms

  • Clinical Decision-Making
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / surgery
  • Esophageal Neoplasms / mortality
  • Esophageal Neoplasms / surgery*
  • Esophagectomy / adverse effects
  • Esophagectomy / methods*
  • Feasibility Studies
  • Gastrectomy / adverse effects
  • Gastrectomy / methods
  • Hepatectomy / adverse effects
  • Hepatectomy / methods
  • Humans
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / surgery
  • Liver Neoplasms / mortality
  • Liver Neoplasms / surgery
  • Lung Neoplasms / mortality
  • Lung Neoplasms / surgery
  • Neoplasms, Multiple Primary / mortality
  • Neoplasms, Multiple Primary / surgery*
  • Nephrectomy / adverse effects
  • Nephrectomy / methods
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / surgery
  • Pancreaticoduodenectomy / adverse effects
  • Pancreaticoduodenectomy / methods
  • Patient Selection*
  • Pneumonectomy / adverse effects
  • Pneumonectomy / methods
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / surgery
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome